<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000367449"><TermName>tetrahydrouridine</TermName><TermPronunciation>(TEH-truh-HY-droh-YOOR-ih-deen)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of some types of cancer. It may help make cancer cells easier to kill with radiation therapy. Tetrahydrouridine is a type of radiosensitizing agent, a type of multidrug resistance modulator, and a type of cytidine deaminase inhibitor. Also called THU.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711515" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tetrahydrouridine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711516" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tetrahidrouridina&quot;" language="es" id="_4"/><SpanishTermName>tetrahidrouridina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. Puede ayudar a facilitar la destrucción de células cancerosas con radioterapia. La tetrahidrouridina es un tipo de radiosensibilizador, un tipo de modulador de la resistencia a múltiples medicamentos y un tipo de inhibidor de la citidina desaminasa. También se llama THU.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-04-23</DateFirstPublished><DateLastModified>2013-04-01</DateLastModified></GlossaryTerm>
